Quarterly report [Sections 13 or 15(d)]

Consolidated Statements of Cash Flows (Unaudited)

v3.25.4
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
9 Months Ended
Dec. 27, 2025
Dec. 28, 2024
OPERATING ACTIVITIES    
Net income (loss) $ 374,202 $ (38,928)
Loss from discontinued operations, net of tax 0 (258,519)
Income from continuing operations, net of tax 374,202 219,591
Adjustments to reconcile net income (loss) to cash provided by operating activities:    
Impairment of goodwill and intangible assets 30,716 51,000
Depreciation and amortization 213,046 186,468
Reduction in the carrying amount of right-of-use assets 265,024 266,823
Stock-based compensation 57,084 52,619
Provision for doubtful accounts 7,821 14,178
Pension expense in excess of (less than) contributions 30,360 4,276
Gain on sale of business (139,068) 0
Other, net 18,309 (31,007)
Changes in operating assets and liabilities:    
Accounts receivable (137,756) (126,720)
Inventories (103,560) (135,156)
Accounts payable 221,431 228,241
Income taxes 15,385 (66,172)
Accrued liabilities 76,080 177,794
Operating lease right-of-use assets and liabilities (263,003) (262,746)
Other assets and liabilities (28,103) 30,356
Cash provided by operating activities - continuing operations 637,968 609,545
Cash provided by operating activities - discontinued operations 0 26,747
Cash provided by operating activities 637,968 636,292
INVESTING ACTIVITIES    
Proceeds from sale of businesses, net of cash sold 600,524 1,485,951
Proceeds from sale of assets 764 88,062
Capital expenditures (87,318) (64,299)
Software purchases (37,165) (29,202)
Other, net (19,138) (30,026)
Cash provided by investing activities - continuing operations 457,667 1,450,486
Cash used by investing activities - discontinued operations 0 (4,413)
Cash provided by investing activities 457,667 1,446,073
FINANCING ACTIVITIES    
Net decrease in short-term borrowings (1,938) (251,131)
Payments on long-term debt (663) (1,000,829)
Payment of debt issuance costs (12,601) 0
Cash dividends paid (105,508) (105,094)
Proceeds from issuance of Common Stock, net of payments for tax withholdings (5,142) (2,628)
Cash used by financing activities (125,852) (1,359,682)
Effect of foreign currency rate changes on cash, cash equivalents and restricted cash 78,300 (28,331)
Net change in cash, cash equivalents and restricted cash 1,048,083 694,352
Cash, cash equivalents and restricted cash – beginning of year 431,475 676,957
Cash, cash equivalents and restricted cash – end of period 1,479,558 1,371,309
Balances per Consolidated Balance Sheets:    
Cash and cash equivalents 1,466,469 1,369,376
Other current assets 13,089 1,933
Total cash, cash equivalents and restricted cash $ 1,479,558 $ 1,371,309